Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $4.93, up $1.75, or 55.03%, on the day. Its market capitalization is $124.54 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data.
  • Hansen Medical, Inc. (NASDAQ:HNSN): The shares closed at $3.54, up $0.28, or 8.59%, on the day. Its market capitalization is $194.29 million. About the company: Hansen Medical, Inc. develops and manufactures medical robotics designed for positioning, manipulation and control of catheters and catheter-based technologies.
  • Delcath Systems, Inc. (NASDAQ:DCTH): The shares closed at $3.69, up $0.28, or 8.21%, on the day. Its market capitalization is $177.10 million. About the company: Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment.
  • Insmed Incorporated (NASDAQ:INSMD): The shares closed at $4.91, up $0.35, or 7.68%, on the day. Its market capitalization is $121.93 million. About the company: Insmed Incorporated is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.
  • Antares Pharma Inc (AMEX:AIS): The shares closed at $2.40, up $0.17, or 7.62%, on the day. Its market capitalization is $247.83 million. About the company: Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Losers (% price change)

  • Skilled Healthcare Group (NYSE:SKH): The shares closed at $3.40, down $0.26, or 7.1%, on the day. Its market capitalization is $129.27 million. About the company: Skilled Healthcare Group Inc. operates nursing and assisted-living homes in California, Texas, Kansas, and Nevada.
  • Vical Incorporated (NASDAQ:VICL): The shares closed at $2.63, down $0.17, or 6.07%, on the day. Its market capitalization is $188.94 million. About the company: Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.
  • United Therapeutics Corp. (NASDAQ:UTHR): The shares closed at $38.35, down $2.36, or 5.8%, on the day. Its market capitalization is $2.24 billion. About the company: United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company’s lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United’s products are currently in Phase III clinical trials.
  • Alphatec Holdings, Inc. (NASDAQ:ATEC): The shares closed at $2.45, down $0.13, or 5.04%, on the day. Its market capitalization is $218.60 million. About the company: Alphatec Holdings, Inc. manufactures medical devices. The Company produces products for the surgical treatment of spinal disorders. Alphatec manufactures spine screws, spinal spacers, and plates.
  • Akorn, Inc. (NASDAQ:AKRX): The shares closed at $8.60, down $0.41, or 4.55%, on the day. Its market capitalization is $813.92 million. About the company: Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>